---
title: "Publications"
layout: default
subtitle: Publications in Li Lab
permalink: /publication
---

# Publications

You can visit [Google Scholar](https://scholar.google.com/citations?user=Nzucqw8AAAAJ&hl=en) or[ORCiD](https://orcid.org/0000-0001-5430-303X) for more details.<br>
\# Co-first authors; \* Co-corresponding authors

## 2024
- Zhiqiang Zhang, Shan Wang, Lulu Jiang, Jianwen Wei, Chang Lu, **Shengli Li**, Yizhu Diao, Zhongcheng Feng, Shuo He, Tingting Tan, Yisheng Yang, Kexin Zou, Jiantao Shi, James Lin, Liye Chen, Chaohui Bao, Jian Fei, and Hai Fang. [Priority index for critical Covid-19 identifies clinically actionable targets and drugs](https://pubmed.ncbi.nlm.nih.gov/38366110/). Communications Biology. 2024 Feb 16;7(1):189.
- Jiling Feng#, Hao Wu#, and **Shengli Li***. Noncanonical translation of circRNAs drive antitumor immunity. Trends in Cancer. 2024 Feb;10(2):100-102.
[[Abstract]](https://pubmed.ncbi.nlm.nih.gov/38242823/)
- Yaoming Liu#, Wei Hu#, Yanjie Xie#, Junjie Tang, Huan Ma, Jinmiao Li, Jiahe Nie, Yinghao Wang, Yang Gao, Chao Cheng, Cheng Li, Yujun Ma, Shicai Su, Zhihui Zhang, Yuekun Bao, Yi Ren, Xinyue Wang, Fengyu Sun, **Shengli Li***, and Rong Lu*. Single-cell transcriptomics enable the characterization of local extension in retinoblastoma. Communications Biology. 2024 Jan 3;7(1):11.
[[Abstract]](https://pubmed.ncbi.nlm.nih.gov/38172218/)

## 2023
- Hao Wu#, Yicheng Lu#, Zhenzhen Duan#, Jingni Wu, Minghui Lin, Yangjun Wu, Siyang Han, Tongqi Li, Yuqi Fan, Xiaoyuan Hu, Hongyan Xiao, Jiaxuan Feng, Zhiqian Lu*, Deping Kong*, **Shengli Li***. Nanopore long-read RNA sequencing reveals functional alternative splicing variants in human vascular smooth muscle cells.
 Communications Biology. 2023 Oct 31;6(1):1104.
[[Abstract]](https://pubmed.ncbi.nlm.nih.gov/37907652/)
- Hao Wang, Yinuo Li, Yanan Wang, Xiumin Shang, Zhongxin Yan, **Shengli Li**, and Wei Bao. Cisplatin-induced PANDAR-Chemo-EVs contribute to a more aggressive and chemoresistant ovarian cancer phenotype through the SRSF9-SIRT4/SIRT6 axis. Journal of Gynecologic Oncology. 2023 Oct 18.
[[Abstract]](https://pubmed.ncbi.nlm.nih.gov/37921598/)
- Yangjun Wu#, Miao Xu#, Zheng Feng#, Hao Wu, Jingni Wu, Xinyu Ha, Yong Wu, Siyu Chen, Fei Xu, Hao Wen, **Shengli Li***, and Xiaohua Wu*. AUF1-induced circular RNA hsa_circ_0010467 promotes platinum resistance of ovarian cancer through miR-637/LIF/STAT3 axis. Cellular and Molecular Life Sciences. 2023 Aug 17;80(9):256.
[[Abstract]](https://pubmed.ncbi.nlm.nih.gov/37589744/)
- Jiling Feng#, Yu Zeng#, and **Shengli Li***. Single-cell characterization of tumor evolution from precursor diseases. Trends in Cancer. 2023 Aug 4;S2405-8033(23)00139-5.
[[Abstract]](https://pubmed.ncbi.nlm.nih.gov/37544795/)
- Hao Wu#, Jiao Wang#, Xiaoyuan Hu, Zhuang Cheng, Jianxin Zhou, Peiru Wu, **Shengli Li***, and Robert Chunhua Zhao*. Comprehensive transcript-level analysis reveals transcriptional reprogramming during the progression of Alzheimer's disease. Frontiers in Aging Neuroscience. 2023 Jun 15;15:1191680.
[[Abstract]](https://pubmed.ncbi.nlm.nih.gov/37396652/)
- Yu Dong#, Qian Gao#, Yong Chen#, Zhao Zhang#, Yanhua Du#, Yuan Liu, Guangxiong Zhang, **Shengli Li**, Gaoyang Wang, Xiang Chen*, Hong Liu*, Leng Han*, and Youqiong Ye*. Identification of circRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy. Nature Communications. 2023 May 3;14(1):2540.
[[Abstract]](https://pubmed.ncbi.nlm.nih.gov/37137884/)
- **Shengli Li#**, Li Yuan#, Zhi-Yuan Xu, Jing-Li Xu, Gui-Ping Chen, Xiaoqing Guan, Guang-Zhao Pan, Can Hu, Jinyun Dong, Yi-An Du, Li-Tao Yang, Mao-Wei Ni, Rui-Bin Jiang, Xiu Zhu, Hang Lv, Han-Dong Xu, Sheng-Jie Zhang, Jiang-Jiang Qin*, and Xiang-Dong Cheng*. ntegrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature Communications. 2023 Feb 11;14(1):778.
[[Abstract]](https://pubmed.ncbi.nlm.nih.gov/36774361/)


